Read More Pharma Industry News Ostia Sciences Inc. closes $1.46m seed financing to accelerate microbiome therapeutics platform development Ostia Sciences Inc. secures $1.46M seed funding to advance SALI-10 microbiome therapeutics for oral health. Analysts expect strong growth in a $3B market. byPallavi MadhirajuJuly 19, 2025